Author:
Bleyzac N,Cuzzubbo D,Rénard C,Garnier N,Dubois V,Domenech C,Goutagny M-P,Plesa A,Grardel N,Goutelle S,Janoly-Duménil A,Bertrand Y
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference58 articles.
1. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 1979; 300: 1068–1073.
2. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555–562.
3. Jiang YZ, Kanfer EJ, Macdonald D, Cullis JO, Goldman JM, Barrett AJ . Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells. Bone Marrow Transplant 1991; 8: 253–258.
4. Keever CA, Klein J, Leong N, Copelan EA, Avalos BR, Kapoor N et al. Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT. Bone Marrow Transplant 1993; 12: 289–295.
5. Kataoka I, Kami M, Takahashi S, Kodera Y, Miyawaki S, Hirabayashi N et al. Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. Bone Marrow Transplant 2004; 34: 711–719.